Kyivmedpreparat Logo

Kyivmedpreparat

Pharmaceutical manufacturer specializing in antibacterial, generic, and original drugs.

KMED | Ukrainian Stock Exchange

Overview

Corporate Details

ISIN(s):
UA4000106140
LEI:
Country:
Ukraine
Address:
139 Saksaganskogo Str., 01032 Kyiv

Description

Kyivmedpreparat is a pharmaceutical manufacturer specializing in the production of antibacterial drugs. The company is a leading producer in this segment and also manufactures a broad portfolio of generic and original medicines. Its products are available in various dosage forms, including injectables. As part of the Arterium Corporation, the company is focused on developing and providing high-quality, patient-centric medicinal solutions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Kyivmedpreparat filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kyivmedpreparat

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kyivmedpreparat via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Lipidor AB Logo
A former developer of topical skin medications using a spray platform; filed for bankruptcy.
Sweden
LIPI
Lipocine Inc. Logo
Develops treatments for metabolic, endocrine, and CNS disorders using drug delivery tech.
United States of America
LPCN
Liquidia Corp Logo
Biopharmaceutical company developing therapies for rare cardiopulmonary diseases.
United States of America
LQDA
LISATA THERAPEUTICS, INC. Logo
Develops therapies to enhance anti-cancer drug delivery to solid tumors.
United States of America
LSTA
Longeveron Inc. Logo
Clinical-stage biotech developing cell therapies for aging and life-threatening conditions.
United States of America
LGVN
Lonza Group AG Logo
A global CDMO for the pharmaceutical, biotech, and nutrition industries.
Switzerland
LONN
Lyell Immunopharma, Inc. Logo
A clinical-stage company developing CAR T-cell therapies for cancer.
United States of America
LYEL
Lyra Therapeutics, Inc. Logo
Clinical-stage biotech developing sinonasal implants to treat chronic rhinosinusitis.
United States of America
LYRA
Lytix Biopharma AS Logo
Clinical-stage immuno-oncology company developing oncolytic molecules for cancer.
Norway
LYTIX
Mabion S.A. Logo
A CDMO providing end-to-end services for protein-based biotherapeutics.
Poland
MAB

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.